Fundraising Fox

PBS Biotech

Camarillo, US · Delaware corporation · 1 known investors

PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.

BiotechHardwareMedical Devices

Founders & leadership

BL
Brian LeeFounder
MC
Matt CroughanExecutive
NB
Nelson BermudezExecutive
TM
Terrell MathewsExecutive
BP
Bryan PoltiloveNamed on SEC filing
JL
Jung LimNamed on SEC filing

Board

XL
Xiaoshen LiaoBoard director
DF
Daniel FriedmanBoard director
DF
Dennis FentonBoard director
LF
Leland FosterBoard director

Investors · 1

Avego BioScience CapitalAlpharetta

Reported raises · per SEC filings

Form D private placements

$43.2M disclosed across 2 rounds · 2022–2024

▶$8.5MraisedSep 2024 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Xiaoshen LiaoDirector
  • Brian LeeExecutive Officer, Director
  • Daniel FriedmanDirector
  • Matt CroughanExecutive Officer
  • Nelson BermudezExecutive Officer
  • Terrell MathewsExecutive Officer
  • Dennis FentonDirector
  • Leland FosterDirector
Offering amount
$17M
Amount sold
$8.5M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34.7MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bryan PoltiloveDirector
  • Dennis FentonDirector
  • Leland fosterDirector
  • Jung LimDirector
  • Brian LeeExecutive Officer, Director
  • Xiaoshen (Jerry) LiaoDirector
Offering amount
$34.7M
Amount sold
$34.7M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Sell or Invest in PBS Biotech Stock Pre-IPOnasdaqprivatemarket.com · Nov 2025PBS Biotech Secures $22 Million to Expand Single-Use Manufacturing Solutions for Cell Therapy Clients - VC Tavernvctavern.com · Aug 2025PBS Biotech: $17 Million In Growth Capital Raisedpulse2.com · Jan 2025PBS Biotech Expands Leadership Team and Secures $17 Million in Growth Capital to Accelerate Delivery of Next Generation Cell and Regenerative Therapiesprnewswire.com · Jan 2025PBS Biotech Raises $17M in Growth Fundingfinsmes.com · Jan 2025PBS Biotech Raises $10M to Provide Scale-Up Manufacturing Solutions for Cell Therapiesbusinesswire.com · Aug 2021

Frequently asked questions

What does PBS Biotech do?
PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.
Who founded PBS Biotech?
PBS Biotech was founded by Brian Lee.
Who are PBS Biotech's investors?
PBS Biotech's investors include Avego BioScience Capital.
How much funding has PBS Biotech raised?
PBS Biotech has disclosed $43.2M raised across 2 rounds.
Where is PBS Biotech headquartered?
PBS Biotech is headquartered in Camarillo, US.